essence semaglutide study Phase 3 Trial of in Metabolic Dysfunction–Associated Steatohepatitis Semaglutide targets MASH molecular pathways – Phase 3 ESSENCE trial: Semaglutide

Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)

The abdomen and thigh are often easier injection sites for self-administration

Brief exposures above this threshold, such as walking from a pharmacy to an air-conditioned car, are unlikely to cause meaningful degradation

Step 4: add water to the semaglutide vial This step is where most mistakes happen

Consult a licensed medspa if side effects persist beyond a few weeks